Glial cell dysregulation: a new perspective on Alzheimer disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neurotoxicity research

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF03033906PMID 18201950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pro-inflammatory conditions promote neuronal damage mediated by Amyloid Precursor Protein and decrease its phagocytosis and degradation by microglial cells in culture.

  2007cited by this paper
• Microglia derived from aging mice exhibit an altered inflammatory profile

  2007cited by this paper
• Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients

  2006cited by this paper
• Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.

  2006cited by this paper
• Altered subcellular location of phosphorylated Smads in Alzheimer's disease

  2006cited by this paper
• Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.

  2006cited by this paper
• The age‐related attenuation in long‐term potentiation is associated with microglial activation

  2006cited by this paper
• SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling*

  2005cited by this paper
• Expression of Scavenger Receptors in Glial Cells

  2005cited by this paper
• Pro- and anti-inflammatory cytokines regulate the ERK pathway: Implication of the timing for the activation of microglial cells

  2005cited by this paper
• Mecanismos neurobiológicos de la enfermedad de Alzheimer

  2005cited by this paper
• Envejecimiento: Cambios bioquímicos y funcionales del Sistema Nervioso Central

  2005cited by this paper
• Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation.

  2005cited by this paper
• Protective Effect of Transforming Growth Factor- 1 on -AmyIoid Neurotoxicity in Rat H ippocampal Neurons

  2005cited by this paper
• SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling.

  2005cited by this paper
• Amyloid-b fibril formation is not necessarily required for microglial activation by the peptides

  2005cited by this paper
• Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes.

  2005influential reference
• Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.

  2005cited by this paper
• The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease.

  2005cited by this paper
• Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture.

  2005cited by this paper
• Infiltration of the brain by pathogens causes Alzheimer's disease.

  2004cited by this paper
• Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

  2004cited by this paper
• Glia Mediates the Neuroprotective Action of Estradiol on β-Amyloid-Induced Neuronal Death

  2004cited by this paper
• Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ

  2004cited by this paper
• Toxicity of Amyloid β Peptide: Tales of Calcium, Mitochondria, and Oxidative Stress

  2004cited by this paper
• Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.

  2004cited by this paper
• Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain

  2004cited by this paper
• Role of insulin-like growth factor I signaling in neurodegenerative diseases

  2004cited by this paper
• Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death.

  2004cited by this paper
• Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation

  2004cited by this paper
• Increased beta-secretase activity and expression in rats following transient cerebral ischemia.

  2004cited by this paper
• Comorbidity in dementia: an autopsy study.

  2004cited by this paper
• Dystrophic microglia in the aging human brain

  2004cited by this paper
• The microglial phagocytic role with specific plaque types in the Alzheimer disease brain.

  2004cited by this paper
• Alzheimer's disease: the two-hit hypothesis

  2004cited by this paper
• Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

  2004cited by this paper
• Synaptic Changes in Alzheimer ’ s Disease Increased Amyloid-and Gliosis in Surviving Terminals Is Accompanied by Decreased PSD-95 Fluorescence

  2004cited by this paper
• Increased β-secretase activity and expression in rats following transient cerebral ischemia

  2004cited by this paper
• Interleukin‐1: A master regulator of neuroinflammation

  2004cited by this paper
• Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors.

  2004influential reference
• Neuroinflammatory perspectives on the two faces of Alzheimer’s disease

  2004cited by this paper
• Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.

  2004cited by this paper
• Astrocyte Protection of Neurons

  2003cited by this paper
• Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity

  2003cited by this paper
• Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double‐stranded RNA

  2003cited by this paper
• NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.

  2003cited by this paper
• Silent brain infarcts and the risk of dementia and cognitive decline.

  2003cited by this paper
• Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: Potential strategies for neuroprotection

  2003cited by this paper
• Peripheral cytokine release in Alzheimer patients: correlation with disease severity.

  2003cited by this paper
• Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits

  2003cited by this paper
• Modification of microglia function protects from lesion‐induced neuronal alterations and promotes sprouting in the hippocampus

  2003cited by this paper
• Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease

  2003cited by this paper
• Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

  2003cited by this paper
• Functional Genomic Analysis of Remyelination Reveals Importance of Inflammation in Oligodendrocyte Regeneration

  2003cited by this paper
• Adult mouse astrocytes degrade amyloid-beta in vitro and in situ.

  2003cited by this paper
• Neuropathology of Cognitively Normal Elderly

  2003cited by this paper
• Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.

  2003cited by this paper
• Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts.

  2003cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of β-Secretase

  2003cited by this paper
• A dual role for interleukin-1 in LTP in mouse hippocampal slices.

  2003cited by this paper
• CD36 Mediates the Innate Host Response to β-Amyloid

  2003cited by this paper
• Dexamethasone Inhibits TNF-α Synthesis More Effectively in Alzheimer’s Disease Patients than in Healthy Individuals

  2003cited by this paper
• Adult mouse astrocytes degrade amyloid-β in vitro and in situ

  2003cited by this paper
• APP processing and synaptic function.

  2003cited by this paper
• Impaired interleukin‐1 signaling is associated with deficits in hippocampal memory processes and neural plasticity

  2003cited by this paper
• NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo

  2003cited by this paper
• Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation.

  2002cited by this paper
• Amyloid-β-induced chemokine production in primary human macrophages and astrocytes

  2002cited by this paper
• Transforming Growth Factor-β1 Increases Bad Phosphorylation and Protects Neurons Against Damage

  2002cited by this paper
• Microglia as neuroprotective, immunocompetent cells of the CNS

  2002influential reference
• Alzheimer Disease as a Vascular Disorder: Nosological Evidence

  2002cited by this paper
• Neuronal changes in normal human aging and Alzheimer's disease.

  2002cited by this paper
• Dysregulation of IFN-gamma signaling pathways in the absence of TGF-beta 1.

  2002cited by this paper
• Dysregulation of IFN-γ Signaling Pathways in the Absence of TGF-β1

  2002cited by this paper
• Dementia epidemiology.

  2002cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide.

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling

  2002cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

  2002cited by this paper
• Neuro–glia interaction effects on GFAP gene: a novel role for transforming growth factor‐β1

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Neuroinflammation in Alzheimer's disease and prion disease

  2002cited by this paper
• Interleukin‐1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease

  2002cited by this paper
• Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

  2002cited by this paper
• Innate immunity: the missing link in neuroprotection and neurodegeneration?

  2002influential reference
• Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

  2002cited by this paper
• Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system

  2002influential reference
• Inflammation in neurodegenerative disease--a double-edged sword.

  2002cited by this paper
• Microglia as a source and target of cytokines

  2002cited by this paper
• CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.

  2002influential reference
• Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Cyclooxygenase‐independent actions of cyclooxygenase inhibitors

  2001cited by this paper
• Immobilized amyloid precursor protein constructs: a tool for the in vitro screening of glial cell reactivity

  2001cited by this paper
• Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain.

  2001cited by this paper

• Differential Glial Response and Neurodegenerative Patterns in CA1, CA3, and DG Hippocampal Regions of 5XFAD Mice

  2024cites this paper
• Microglial reactivity in brainstem chemosensory nuclei in response to hypercapnia

  2024influential citation
• Ageing-related changes in the regulation of microglia and their interaction with neurons.

  2024cites this paper
• Dual role of nitric oxide in Alzheimer's Disease.

  2023cites this paper
• Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases

  2023influential citation
• Connecting the Dots: Neuronal Senescence, Stress Granules, and Neurodegeneration.

  2023cites this paper
• Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice

  2023cites this paper
• NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer’s Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss

  2022cites this paper
• Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.

  2022cites this paper
• COVID-19 and Postural Control—A Stabilographic Study Using Rambling-Trembling Decomposition Method

  2022cites this paper
• Disrupted long-range gene regulations elucidate shared tissue-specific mechanisms of neuropsychiatric disorders

  2022cites this paper
• Neuroprotective effects on microglia and insights into the structure–activity relationship of an antioxidant peptide isolated from Pelophylax perezi

  2022cites this paper
• Signalling Pathways Involved in Microglial Activation in Alzheimer's Disease and Potential Neuroprotective Role of Phytoconstituents.

  2022cites this paper
• Sex-dependent worsening of NMDA-induced responses, anxiety, hypercortisolemia, and organometry of early peripheral immunoendocrine impairment in adult 3xTg-AD mice and their long-lasting ontogenic modulation by neonatal handling.

  2022cites this paper
• Role of caveolin-1 in metabolic programming of fetal brain

  2022cites this paper
• The impact of aged microglia on d-serine-regulated glutamatergic transmission

  2021cites this paper
• Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action

  2021cites this paper
• The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases.

  2021cites this paper
• Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients

  2020cites this paper
• How Repair-or-Dispose Decisions Under Stress Can Initiate Disease Progression

  2020cites this paper
• Cellular Senescence in Neurodegenerative Diseases

  2020cites this paper
• Polyphenols as an Effective Therapeutic Intervention Against Cognitive Decline During Normal and Pathological Brain Aging.

  2020cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• A model of neuron-glia crosstalk explains stages of neural tissue resilience

  2019cites this paper
• To the question of neuroimmune mechanisms in the formation of perinatal brain damage

  2019cites this paper
• Development of a Multimodal MRI Study to Characterize Morpho-Functional Features in Rodent Models of Alzheimer's Disease

  2019cites this paper
• X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.

  2019cites this paper
• Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats.

  2019cites this paper
• Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease

  2019cites this paper
• Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.

  2018cites this paper
• Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress

  2018cites this paper
• Impact of Aging in Microglia-Mediated D-Serine Balance in the CNS

  2018cites this paper
• Perfluorooctanesulfonate induces neuroinflammation through the secretion of TNF‐&agr; mediated by the JAK2/STAT3 pathway

  2018cites this paper
• Perfluorooctane sulfonate mediates secretion of IL-1β through PI3K/AKT NF-кB pathway in astrocytes.

  2018cites this paper
• Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia

  2018cites this paper
• Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats

  2018influential citation
• Microglial priming in Alzheimer's disease.

  2018cites this paper
• The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD

  2018cites this paper
• Different Patterns of Neurodegeneration and Glia Activation in CA1 and CA3 Hippocampal Regions of TgCRND8 Mice

  2018cites this paper
• Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-κB and AP-1 Signaling Pathways In Vitro

  2018cites this paper
• Dementia Research: Populations, Progress, Problems, and Predictions

  2018cites this paper
• Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.

  2017cites this paper
• (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats

  2017cites this paper
• Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer’s Disease

  2017cites this paper
• Sausage tree (Kigelia africana) flavonoid extract is neuroprotective in AlCl3-induced experimental Alzheimer's disease.

  2017cites this paper
• The Role of Lipid Bodies in the Microglial Aging Process and Related Diseases

  2017cites this paper
• Genome instability: Linking ageing and brain degeneration.

  2017cites this paper
• Cognitive impairment and neuronal damage in Alzheimer's disease are malleable: occupational chlorpyrifos exposure exacerbates phenotypes, while the neuroprotective compound P7C3 ameliorates effects in a transgenic model of Alzheimer's disease.

  2017cites this paper
• The Ageing Immune System and Health

  2017cites this paper
• Microglia Function in the Normal Brain.

  2016cites this paper
• An overview of CEST MRI for non-MR physicists

  2016cites this paper
• Lamotrigine Reduces Inflammatory Response and Ameliorates Executive Function Deterioration in an Alzheimer's-Like Mouse Model

  2016cites this paper
• Age-Dependent Changes in the Activation and Regulation of Microglia.

  2016cites this paper
• KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.

  2016cites this paper
• Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer’s Disease

  2016cites this paper
• Glial Cells and Integrity of the Nervous System.

  2016cites this paper
• Elucidating the link between the modifiable risk factors of Alzheimer's disease and neuroinflammation.

  2016cites this paper
• APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.

  2015cites this paper
• Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

  2015cites this paper
• 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice

  2015cites this paper
• Microglial cell dysregulation in brain aging and neurodegeneration

  2015influential citation
• MHz Electromagnetic Fields Ameliorate A β Pathology in Alzheimer ’ s Disease Mice

  2015cites this paper
• Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease

  2015cites this paper
• Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease

  2015influential citation
• Melatonin and brain inflammaging.

  2015cites this paper
• Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β.

  2015cites this paper
• Activation of the factor XII-driven contact system in Alzheimer’s disease patient and mouse model plasma

  2015cites this paper
• Loading into Nanoparticles Improves Quercetin's Efficacy in Preventing Neuroinflammation Induced by Oxysterols

  2014cites this paper
• Microglia in the Alzheimers brain: a help or a hindrance?

  2014cites this paper
• Sympathetic glial cells and macrophages develop different responses to Trypanosoma cruzi infection or lipopolysaccharide stimulation

  2014cites this paper
• Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.

  2014cites this paper
• EVIDENCES FOR THE PROMISING THERAPEUTIC POTENTIAL OF BOSWELLIA SERRATA AGAINST ALZHEIMER'S DISEASE: PRE-CLINICAL STUDY

  2014cites this paper
• Role of estrogen hormone in lipopolysaccharide: induced Alzheimer's disease in female rats; possible underlying mechanisms and modulation by progesterone hormone

  2014cites this paper
• Single-Walled Carbon Nanotubes Alleviate Autophagic/Lysosomal Defects in Primary Glia from a Mouse Model of Alzheimer’s Disease

  2014cites this paper
• Rcor2 underexpression in senescent mice: a target for inflammaging?

  2014cites this paper
• Osteopontin Expression During the Acute Immune Response Mediates Reactive Synaptogenesis and Adaptive Outcome

  2013cites this paper
• MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease.

  2013cites this paper
• A new interpretative paradigm for Conformational Protein Diseases.

  2013cites this paper
• Inflammation and cytokine production in experimental neuroinflammatory disorders

  2013cites this paper
• Evaluación del efecto neuroprotector de A91 sobre la apoptosis, en ratas con lesión traumática de médula espinal

  2013cites this paper
• The aqueous extract from Toona sinensis leaves inhibits microglia‐mediated neuroinflammation

  2013cites this paper
• SR-A Regulates the Inflammatory Activation of Astrocytes

  2013cites this paper
• Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer's Disease

  2013cites this paper
• POSSIBLE THERAPEUTIC ROLE OF JASONIA CANDICANS AND JASONIA MONTANA EXTRACTS IN THE REGRESSION OF ALZHEIMER'S DISEASE IN EXPERIMENTAL MODEL

  2013cites this paper
• AMELIORATION OF NEUROINFLAMMATION AND APOPTOSIS CHARACTERIZING ALZHEIMER'S DISEASE BY NATURAL PRODUCTS

  2013cites this paper
• The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD

  2013cites this paper
• The Role of the Innate Immune System in Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia

  2013cites this paper
• Astrocytes inhibit nitric oxide‐dependent Ca2+ dynamics in activated microglia: Involvement of ATP released via pannexin 1 channels

  2013cites this paper
• ICEST : A potential tool for non-invasive detection of molecular changes in lzheimer ’ s disease

  2012cites this paper
• Iron toxicity in neurodegeneration

  2012cites this paper
• Transforming growth factor‐β stimulates β amyloid uptake by microglia through Smad3‐dependent mechanisms

  2012cites this paper
• Scavenger receptor class A ligands induce secretion of IL1β and exert a modulatory effect on the inflammatory activation of astrocytes in culture.

  2012cites this paper
• Modulation of interferon‐γ‐induced glial cell activation by transforming growth factor β1: A role for STAT1 and MAPK pathways

  2012cites this paper
• Neuroprotective Effect of Natural Products Against Alzheimer’s Disease

  2012cites this paper
• Triggering Microglia Oncotoxicity: A Bench Utopia or a Therapeutic Approach?

  2012cites this paper
• IMMUNE MECHANISMS ASSOCIATED TO NEUROINFLAMMATION IN ALZHEIMER'S DISEASE

  2012cites this paper
• Aβ Potentiates Inflammatory Activation of Glial Cells Induced by Scavenger Receptor Ligands and Inflammatory Mediators in Culture

  2012cites this paper
• The Importance of the Environment in Brain Aging: Be Happy, Live Longer!

  2012cites this paper
• Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

  2012influential citation
• Neuroinflammation is a generally beneficial process mediated by the activation of glial cells in response to injury, illness, or infection. Astrocytes and microglia release inflammatory mediators like cytokines and radical species like nitric oxide (NOÆ) and superoxide anion (O2Æ

  2012cites this paper